Prostreat Seen as Better Than Current Therapies at Stopping Aggressive Prostate Cancer in Mice

Prostreat Seen as Better Than Current Therapies at Stopping Aggressive Prostate Cancer in Mice
NucleoBio’s investigative therapy Prostreat was seen to be better at preventing the growth and spread of metastatic castration-resistant prostate cancer than currently available hormone therapies, a mouse study showed. The treatment was effective even in cells with a variant of the androgen receptor that renders them resistant to treatment, setting the basis for the development

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *